Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.9%

9 terminated/withdrawn out of 228 trials

Success Rate

90.7%

+4.2% vs industry average

Late-Stage Pipeline

21%

47 trials in Phase 3/4

Results Transparency

2 of 88 completed trials have results

Key Signals

28 recruiting2 with results7 terminated

Enrollment Performance

Analytics

N/A

64(45.7%)

Phase 4

35(25.0%)

Phase 2

27(19.3%)

Phase 3

12(8.6%)

Phase 1

1(0.7%)

Early Phase 1

1(0.7%)

140Total

N/A(64)

Phase 4(35)

Phase 2(27)

Phase 3(12)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (228)

Showing 20 of 228 trials

NCT07033312Not ApplicableCompleted

Therapeutic Effect of Oral Hyaluronic Acid on Knee Osteoarthritis

Role: lead

NCT06503120Not ApplicableActive Not Recruiting

Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Role: lead

NCT05410496Phase 4Active Not Recruiting

Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection

Role: lead

NCT03624751Active Not Recruiting

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Role: lead

NCT05199324Phase 4Recruiting

Early Oral Switch for Uncomplicated Gram-negative Bacteraemia

Role: collaborator

NCT04180072Not ApplicableActive Not Recruiting

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Role: collaborator

NCT06127446Recruiting

The Registry of Genetic Alterations of Taiwan Ovarian Cancer

Role: collaborator

NCT05048901Phase 1Recruiting

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Role: collaborator

NCT07487636Not ApplicableEnrolling By Invitation

4DryField PH and Head and Neck Operations.

Role: lead

NCT07180173Completed

Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study

Role: lead

NCT07479147Recruiting

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

Role: lead

NCT07378319Not ApplicableRecruiting

Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.

Role: lead

NCT07453953Early Phase 1Not Yet Recruiting

A Comparison of Clinical Efficacy of Mytocel MSK With AMT and PRP Injections in Patients With Knee Osteoarthritis

Role: lead

NCT06322810Not ApplicableRecruiting

ESP Versus PIFB for Analgesia in Open Cardiac Surgery: a Randomized Control Trial

Role: lead

NCT06557668Recruiting

Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer

Role: lead

NCT07369791Phase 2Not Yet Recruiting

Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.

Role: collaborator

NCT07363876Not ApplicableNot Yet Recruiting

The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis

Role: lead

NCT05026905Phase 2Active Not Recruiting

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Role: collaborator

NCT04821895Active Not Recruiting

Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

Role: collaborator

NCT05522881Recruiting

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

Role: collaborator